Endotoxin-Induced Endothelial Fibrosis Is Dependent on Expression of Transforming Growth Factors β1 and β2
Open Access
- 1 September 2014
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 82 (9) , 3678-3686
Abstract
During endotoxemia-induced inflammatory disease, bacterial endotoxins circulate in the bloodstream and interact with endothelial cells (ECs), inducing dysfunction of the ECs. We previously reported that endotoxins induce the conversion of ECs into activated fibroblasts. Through endotoxin-induced endothelial fibrosis, ECs change their morphology and their protein expression pattern, thereby suppressing endothelial markers and upregulating fibrotic proteins. The most commonly used fibrotic inducers are transforming growth factor β1 (TGF-β1) and TGF-β2. However, whether TGF-β1 and TGF-β2 participate in endotoxin-induced endothelial fibrosis remains unknown. We have shown that the endotoxin-induced endothelial fibrosis process is dependent on the TGF-β receptor, ALK5, and the activation of Smad3, a protein that is activated by ALK5 activation, thus suggesting that endotoxin elicits TGF-β production to mediate endotoxin-induced endothelial fibrosis. Therefore, we investigated the dependence of endotoxin-induced endothelial fibrosis on the expression of TGF-β1 and TGF-β2. Endotoxin-treated ECs induced the expression and secretion of TGF-β1 and TGF-β2. TGF-β1 and TGF-β2 downregulation inhibited the endotoxin-induced changes in the endothelial marker VE-cadherin and in the fibrotic proteins α-SMA and fibronectin. Thus, endotoxin induces the production of TGF-β1 and TGF-β2 as a mechanism to promote endotoxin-induced endothelial fibrosis. To the best of our knowledge, this is the first report showing that endotoxin induces endothelial fibrosis via TGF-β secretion, which represents an emerging source of vascular dysfunction. These findings contribute to understanding the molecular mechanism of endotoxin-induced endothelial fibrosis, which could be useful in the treatment of inflammatory diseases.Keywords
This publication has 36 references indexed in Scilit:
- Angiotensin II-induced pro-fibrotic effects require p38MAPK activity and transforming growth factor beta 1 expression in skeletal muscle cellsThe International Journal of Biochemistry & Cell Biology, 2012
- Transforming growth factor-β2 promotes Snail-mediated endothelial–mesenchymal transition through convergence of Smad-dependent and Smad-independent signallingBiochemical Journal, 2011
- TGF-β/TGF-β receptor system and its role in physiological and pathological conditionsClinical Science, 2011
- Bacterial lipopolysaccharide promotes profibrotic activation of intestinal fibroblastsBritish Journal of Surgery, 2010
- The role of endothelial-to-mesenchymal transition in cancer progressionBritish Journal of Cancer, 2008
- TLR4 signaling promotes the expression of VEGF and TGFβ1 in human prostate epithelial PC3 cells induced by lipopolysaccharideCellular Immunology, 2008
- Discovery of Endothelial to Mesenchymal Transition as a Source for Carcinoma-Associated FibroblastsCancer Research, 2007
- p38 Mitogen-activated protein kinase and alkaline phosphatase in human dental pulp cellsOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 2006
- Three Key Residues Underlie the Differential Affinity of the TGFβ Isoforms for the TGFβ Type II ReceptorJournal of Molecular Biology, 2006
- Myofibroblasts and mechano-regulation of connective tissue remodellingNature Reviews Molecular Cell Biology, 2002